PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
Volume 8 Issue 4

Peptide Libraries: Expanding Frontiers in Drug Discovery and Development

Peptide libraries have emerged as a transformative technology in drug discovery and development. These diverse collections of peptides, now mainly synthetic but also...
Continue Reading →
Volume 8 Issue 4

Innovative Solutions for Future Cell Culture Development

The world is still confronting complex and urgent challenges. Populations continue to grow, while many societies are ageing, placing heavy burdens of chronic and deg...
Continue Reading →
Volume 8 Issue 4

Powering the Future of Cell Therapy: Building Scalable Cell Therapy Manufacturing Across the UK

Chimeric antigen receptor (CAR) T-cell therapy is one of the most transformative breakthroughs in modern medicine. The concept of reprogramming a patient’s own immun...
Continue Reading →
Volume 8 Issue 4

Is the PROTAC Party Just Getting Started?

A little over five years ago, the biotech world became intrigued with the promise of Antibody–Drug Conjugates (ADCs). Investors poured resources into CDMOs and produ...
Continue Reading →
Volume 8 Issue 4

Moving Batch Release into the Fast Lane

Speeding products to market requires a precise balance between efficiency and compliance. By streamlining complex workflows, a centralised and automated approach to ...
Continue Reading →
Volume 8 Issue 4

Advanced Flow Cytometry Solutions for Drug Development: A Focus on B Cells and T Cells

If you have trained in the field of immunology, it may not be uncommon to emerge with a self-characterisation as either a “B cell immunologist” or a “T cell immunolo...
Continue Reading →
Volume 8 Issue 4

The Growing Potential of Monodisperse PEG 2000 and PEG 5000 Applications

Quality and defined chemical composition are essential for pharmaceutical formulations. Purity requirements dictated by regulatory agencies and pharmacopoeias ensure...
Continue Reading →
Volume 8 Issue 4

Evolving Feasibility in Oncology: Continuous Assessment for Timely Enrollment

Sponsors and CROs are familiar with the definition of feasibility as the process of evaluating whether, and how, a clinical trial can be conducted successfully. This...
Continue Reading →
Volume 8 Issue 3

An Expertise and Dedication to Advancing Cell Therapy Manufacturing: An Interview with Camille Bachelet of CELLforCURE by SEQENS

Can you please start by providing a brief overview of CELLforCURE’s history and how the company hasdeveloped since being founded? Founded in 2010 by LFB, a Fr...
Continue Reading →
Volume 8 Issue 3

Pharma Glass Packaging Development for Patient Safety:Cangzhou Four Stars Glass Co. Explains The Pioneering Strides Takento Become a Preferred Partner for your Pharmaceuticals

Can you please start by providing a brief overview of Four Stars Glass’ history and how the company has developed since being founded? In 1998, Four Stars, v...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC